These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 12439833

  • 1. Subjective emotional experience and cognitive impairment in drug-induced akathisia.
    Kim JH, Lee BC, Park HJ, Ahn YM, Kang UG, Kim YS.
    Compr Psychiatry; 2002; 43(6):456-62. PubMed ID: 12439833
    [Abstract] [Full Text] [Related]

  • 2. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol.
    Kim JH, Byun HJ.
    J Clin Pharm Ther; 2007 Oct; 32(5):461-7. PubMed ID: 17875112
    [Abstract] [Full Text] [Related]

  • 3. The relationship between akathisia and subjective tolerability in patients with schizophrenia.
    Kim JH, Byun HJ.
    Int J Neurosci; 2010 Jul; 120(7):507-11. PubMed ID: 20583904
    [Abstract] [Full Text] [Related]

  • 4. [Subjective experiences of patients with acute neuroleptic-induced akathisia].
    Gruber O, Northoff G, Pflug B.
    Fortschr Neurol Psychiatr; 1998 Dec; 66(12):531-8. PubMed ID: 9922925
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
    Poyurovsky M, Epshtein S, Fuchs C, Schneidman M, Weizman R, Weizman A.
    J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
    [Abstract] [Full Text] [Related]

  • 6. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia.
    Janno S, Holi MM, Tuisku K, Wahlbeck K.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):39-41. PubMed ID: 15572272
    [Abstract] [Full Text] [Related]

  • 7. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].
    Cipolli C, Chiari G.
    Clin Ter; 1990 Mar 31; 132(6 Suppl):479-510. PubMed ID: 2140973
    [Abstract] [Full Text] [Related]

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec 31; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 9. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA, Brecher M, Paulsson B.
    Bipolar Disord; 2006 Oct 31; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [Abstract] [Full Text] [Related]

  • 10. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T.
    Psychiatry Clin Neurosci; 2008 Aug 31; 62(4):404-11. PubMed ID: 18778437
    [Abstract] [Full Text] [Related]

  • 11. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia.
    Sachdev P, Hume F, Toohey P, Doutney C.
    Acta Psychiatr Scand; 1996 Jun 31; 93(6):451-9. PubMed ID: 8831862
    [Abstract] [Full Text] [Related]

  • 12. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y, Kitabayashi Y, Narumoto J, Nakamura K, Ueda H, Fukui K.
    Psychiatry Clin Neurosci; 2005 Dec 31; 59(6):697-704. PubMed ID: 16401246
    [Abstract] [Full Text] [Related]

  • 13. Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture.
    Lenze EJ, Munin MC, Dew MA, Rogers JC, Seligman K, Mulsant BH, Reynolds CF.
    Int J Geriatr Psychiatry; 2004 May 31; 19(5):472-8. PubMed ID: 15156549
    [Abstract] [Full Text] [Related]

  • 14. Subjective cognitive dysfunction associated with drug-induced parkinsonism in schizophrenia.
    Kim JH, Kim SY, Byun HJ.
    Parkinsonism Relat Disord; 2008 May 31; 14(3):239-42. PubMed ID: 17851106
    [Abstract] [Full Text] [Related]

  • 15. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.
    Putzhammer A, Perfahl M, Pfeiff L, Hajak G.
    Pharmacopsychiatry; 2005 May 31; 38(3):132-8. PubMed ID: 15902585
    [Abstract] [Full Text] [Related]

  • 16. Emotional withdrawal, CT abnormalities and drug response in late life depression.
    Altamura AC, Bassetti R, Santini A, Frisoni GB, Mundo E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar 31; 28(2):349-54. PubMed ID: 14751432
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: the Memory and Medical Care Study.
    Chan DC, Kasper JD, Black BS, Rabins PV.
    Int J Geriatr Psychiatry; 2003 Feb 31; 18(2):174-82. PubMed ID: 12571828
    [Abstract] [Full Text] [Related]

  • 18. Neuroleptic-induced acute and chronic akathisia: a clinical comparison.
    Kim JH, Jin YH, Kang UG, Ahn YM, Ha KS, Kim YS.
    Mov Disord; 2005 Dec 31; 20(12):1667-70. PubMed ID: 16078203
    [Abstract] [Full Text] [Related]

  • 19. Use of questionnaire infeasibility in order to detect cognitive disorders: example of the Center for Epidemiologic Studies Depression Scale in psychiatry settings.
    Nishiyama T, Ozaki N, Iwata N.
    Psychiatry Clin Neurosci; 2009 Feb 31; 63(1):23-9. PubMed ID: 19154209
    [Abstract] [Full Text] [Related]

  • 20. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.
    Encephale; 2003 Feb 31; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.